Researchers simulated nearly every molecule in a bacterial cell — and then watched the cell grow and reproduce.
University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.